Clinical Outcomes of Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation
Top Cited Papers
Open Access
- 1 April 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 40 (7) , 932-940
- https://doi.org/10.1086/428060
Abstract
Background. Although human herpesvirus 6 (HHV-6) is known to reactivate during hematopoietic stem cell transplantation (HSCT), the clinical significance of this finding is controversial.Keywords
This publication has 44 references indexed in Scilit:
- Optimization of Quantitative Detection of Cytomegalovirus DNA in Plasma by Real-Time PCRJournal of Clinical Microbiology, 2004
- Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantationBlood, 2003
- Human Herpesvirus 6 Viremia in Bone Marrow Transplant Recipients: Clinical Features and Risk FactorsThe Journal of Infectious Diseases, 2002
- Effect of Antivirals on Human Herpesvirus 6 Replication in Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 2002
- Human Herpesvirus 6 Reactivation and Encephalitis in Allogeneic Bone Marrow Transplant RecipientsClinical Infectious Diseases, 2001
- High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patientsBritish Journal of Haematology, 2000
- Human Herpesvirus 6 Infections after Bone Marrow Transplantation: Clinical and Virologic ManifestationsThe Journal of Infectious Diseases, 1999
- Human Herpesvirus 6 in Lung Tissue from Patients with Pneumonitis after Bone Marrow TransplantationNew England Journal of Medicine, 1993
- AGE PREVALENCE OF ANTIBODY TO HUMAN HERPESVIRUS 6The Lancet, 1988
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974